Victory Capital Management Inc. Reduces Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Victory Capital Management Inc. lowered its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 31.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,143,602 shares of the company's stock after selling 519,066 shares during the period. Victory Capital Management Inc. owned approximately 2.31% of Prestige Consumer Healthcare worth $98,315,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. CIBC Private Wealth Group LLC increased its holdings in Prestige Consumer Healthcare by 48.9% during the fourth quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock valued at $34,000 after buying an additional 152 shares during the period. Opal Wealth Advisors LLC purchased a new position in Prestige Consumer Healthcare during the first quarter valued at approximately $38,000. Headlands Technologies LLC purchased a new position in Prestige Consumer Healthcare in the fourth quarter worth $40,000. McIlrath & Eck LLC grew its holdings in Prestige Consumer Healthcare by 19.1% in the fourth quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock worth $75,000 after purchasing an additional 154 shares during the last quarter. Finally, Johnson Financial Group Inc. purchased a new position in Prestige Consumer Healthcare in the fourth quarter worth $93,000. Institutional investors own 99.95% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. Wall Street Zen raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, Prestige Consumer Healthcare currently has a consensus rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Price Performance

Shares of Prestige Consumer Healthcare stock traded down $0.13 during trading hours on Monday, reaching $75.65. The stock had a trading volume of 425,237 shares, compared to its average volume of 317,247. The stock's 50 day moving average is $82.92 and its 200 day moving average is $82.32. The firm has a market capitalization of $3.74 billion, a PE ratio of 16.73, a PEG ratio of 2.27 and a beta of 0.43. Prestige Consumer Healthcare Inc. has a twelve month low of $64.94 and a twelve month high of $90.04. The company has a current ratio of 4.20, a quick ratio of 2.82 and a debt-to-equity ratio of 0.55.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $1.32 EPS for the quarter, topping analysts' consensus estimates of $1.30 by $0.02. The business had revenue of $296.52 million during the quarter, compared to analysts' expectations of $289.36 million. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The company's quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.02 earnings per share. Equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.